(Q79179027)
Statements
Comparison of costs associated with the use of etanercept, infliximab, and adalimumab for the treatment of rheumatoid arthritis (English)
Michael F Bullano
Brian J McNeeley
Yanni F Yu
Ralph Quimbo
Lauren P Burawski
Elaine B Yu
J Michael Woolley
1 September 2006